RioGen
RioGen is a biotechnology startup founded in 2021, based at the Federal University of Rio de Janeiro (UFRJ). The company focuses on developing non-invasive molecular diagnostic tests for cancer patients, utilizing biomarker prospecting, machine learning, and genetic signature identification to create fast and accurate exams. Their primary goal is to improve cancer diagnosis and monitoring, aiming to reduce unnecessary invasive procedures like prostate biopsies. RioGen also offers R&D and bioinformatics consulting services, including genome and transcriptome analysis and biomarker prospecting.
RioGen
RioGen is a biotechnology startup founded in 2021, based at the Federal University of Rio de Janeiro (UFRJ). The company focuses on developing non-invasive molecular diagnostic tests for cancer patients, utilizing biomarker prospecting, machine learning, and genetic signature identification to create fast and accurate exams. Their primary goal is to improve cancer diagnosis and monitoring, aiming to reduce unnecessary invasive procedures like prostate biopsies. RioGen also offers R&D and bioinformatics consulting services, including genome and transcriptome analysis and biomarker prospecting.